Patients randomized to TAVR in this study received the Medtronic Evolut R, PRO or CoreValve bioprosthesis as new generation valves became available during the study. Aortic stenosis—when the valve in ...

Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

The US FDA has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system.

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. A higher proportion of ...

The message that Ainnova’s CEO, Vinicio Vargas, continues to convey to audiences around the world is that this accessible, fast, and scalable solution is designed to support early intervention and ...

1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut R, PRO, or CoreValveTM and 684 undergoing surgery. Spectral AI, Inc. (NASDAQ: MDAI) , a leading developer of the ...

We came across a bullish thesis on Medtronic plc (MDT) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on MDT. Medtronic plc (MDT)’s share was trading at $ ...

Recent iterations of the Evolut valve system are intended to reduce PVL, but the effects of oversizing with such valves on PVL are largely unknown. We aimed to assess, in a real-world contemporary ...

KIMS Sunshine Hospital, Hyderabad, has joined hands with Medtronic, a medical device manufacturer, to establish a specialised centre for renal denervation therapy. The partnership, formalised ...

KIMS-Sunshine Hospital has partnered with Medtronic, a medical technology player, to establish a specialised center for renal denervation therapy. Through this initiative, Medtronic will support ...

March 18, 2025 FDA classifies recall of Medtronic embolization devices as 'most serious' The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device ...

Laura Endres, new head of Americas for Medtronic Diabetes. [Image from LinkedIn] Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.